Anuradha Banerjee MD


Associate Clinical Professor of Pediatrics and Neurological Surgery

Pediatric Neuro-oncologist


Dr. Banerjee is a pediatrician with fellowship training in pediatric hematology and oncology. She is also an epidemiologist and has a special interest in pediatric palliative care. Her research focuses on the use of convection-enhanced delivery of novel drugs for treatment of high-grade glioma, as well as other treatment strategies for brainstem glioma.  



Education, Training, and Previous Positions

1987: BA, Stanford University
1996: BA, Harvard University
1990: MPH, Tulane School of Public Health
1992: MD, Tulane School of Medicine
1992-1996: Residency in Pediatrics, UCSF
1999-2001: Assistant Clinical Professor of Pediatrics, UCSF
2001-Present: Department of Neurological Surgery, UCSF

Selected Professional Memberships and Appointments

American Association for Cancer Research
American Society of Clinical Oncology
Children's Oncology Group
Pediatric Brain Tumor Consortium
Society for Neuro-Oncology
The American Society of Pediatric Hematology/Oncology

Selected Recent Publications

Nordstrom M, Felton E, Sear K, Tamrazi B, Torkildson J, Gauvain K, Haas-Kogan DA, Chen J, Buono BD, Banerjee A, Samuel D, Saloner D, Tian B, Roddy E, Hess C, Fullerton H, Mueller S. Large Vessel Arteriopathy After Cranial Radiation Therapy in Pediatric Brain Tumor Survivors. J Child Neurol. 2018 Apr;33(5):359-366. doi: 10.1177/0883073818756729. PubMed PMID: 29575995; PubMed Central PMCID: PMC5873308.

Iorgulescu JB, Van Ziffle J, Stevers M, Grenert JP, Bastian BC, Chavez L, Stichel D, Buchhalter I, Samuel D, Nicolaides T, Banerjee A, Mueller S, Gupta N, Tihan T, Bollen AW, Northcott PA, Kool M, Pfister S, Korshunov A, Perry A, Solomon DA. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation. Acta Neuropathol. 2018 Apr;135(4):635-638. doi: 10.1007/s00401-018-1819-x. Epub 2018 Feb 12. PubMed PMID: 29435664.

Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, Torkildson J, Samuel D, Bloomer M, Campomanes AGA, Banerjee A, Butowski N, Raffel C, Tihan T, Bollen AW, Phillips JJ, Korn WM, Yeh I, Bastian BC, Gupta N, Mueller S, Perry A, Nicolaides T, Solomon DA. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 2017 May 1;19(5):699-709. doi: 10.1093/neuonc/now254. PubMed PMID: 28453743; PubMed Central PMCID: PMC5464451.

Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, Goldman S, Doyle LA, Stewart CF, Boyett JM, Kun LE, Fouladi M. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol. 2017 Aug 1;19(8):1135-1144. doi: 10.1093/neuonc/now282. PubMed PMID: 28339824; PubMed Central PMCID: PMC5570236.

Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Buono BD, Samuel D, Haas-Kogan DA, Chen J, Goldsby RE, Banerjee A, Lupo JM, Molinaro AM, Fullerton HJ, Mueller S. Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro Oncol. 2016 Nov;18(11):1548-1558. Epub 2016 Aug 18. PubMed PMID: 27540084; PubMed Central PMCID: PMC5063522.

Barajas RF Jr, Phelps A, Foster HC, Courtier J, Buelow BD, Gupta N, Nicolaides T, Glenn OA, Banerjee A. Metastatic Diffuse Intrinsic Pontine Glioma to the Peritoneal Cavity Via Ventriculoperitoneal Shunt: Case Report and Literature Review. J Neurol Surg Rep. 2015 Jul;76(1):e91-6. doi: 10.1055/s-0035-1547365. Epub 2015 Apr 27. PubMed PMID: 26251821; PubMed Central PMCID: PMC4520967.

Kilburn LB, Kocak M, Decker RL, Wetmore C, Chintagumpala M, Su J, Goldman S, Banerjee A, Gilbertson R, Fouladi M, Kun L, Boyett JM, Blaney SM. A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. Neuro Oncol. 2015 Feb;17(2):303-11. doi: 10.1093/neuonc/nou114. Epub 2014 Nov 27. PubMed PMID: 25431212; PubMed Central PMCID: PMC4288513.

Thampi S, Hetts SW, Cooke DL, Stewart PJ, Robbins E, Banerjee A, Dubois SG, Char D, Halbach V, Matthay K. Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol. 2013;7:981-9. doi: 10.2147/OPTH.S43398. Epub 2013 May 27. PubMed PMID: 23818751; PubMed Central PMCID: PMC3693581.

Kilburn LB, Kocak M, Schaedeli Stark F, Meneses-Lorente G, Brownstein C, Hussain S, Chintagumpala M, Thompson PA, Gururangan S, Banerjee A, Paulino AC, Kun L, Boyett JM, Blaney SM. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun;15(6):759-66. doi: 10.1093/neuonc/nos315. Epub 2013 Apr 16. PubMed PMID: 23592571; PubMed Central PMCID: PMC3661085.